Beyond CLL, ROR1 has been implicated in other hematologic malignancies, including acute lymphoblastic leukemia (ALL), non-Hodgkin lymphomas (NHLs), and myeloid malignancies (27–30). Here, ROR1 is linked to myeloid neoplasm.